D.E. Shaw & Co
KYMR icon

D.E. Shaw & Co’s Kymera Therapeutics KYMR Stock Holding History

D.E. Shaw & Co’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-82,578
Closed -$3.32M – 4548
2024
Q4 		$3.32M Sell
82,578
-105,619
-56% -$4.77M ﹤0.01% 2313
2024
Q3 		$8.91M Sell
188,197
-107,375
-36% -$4.74M 0.01% 1498
2024
Q2 		$8.82M Buy
295,572
+227,810
+336% +$7.89M 0.01% 1410
2024
Q1 		$2.72M Buy
+67,762
New +$2.42M ﹤0.01% 2387
2023
Q2 		– Sell
-27,032
Closed -$801K – 4422
2023
Q1 		$801K Buy
27,032
+13,553
+101% +$437K ﹤0.01% 3307
2022
Q4 		$336K Buy
13,479
+2,662
+25% +$71K ﹤0.01% 4042
2022
Q3 		$235K Buy
+10,817
New +$285K ﹤0.01% 4406
2021
Q2 		– Sell
-14,645
Closed -$569K – 4915
2021
Q1 		$569K Sell
14,645
-16,947
-54% -$1.02M ﹤0.01% 3449
2020
Q4 		$1.96M Buy
+31,592
New +$1.54M ﹤0.01% 2569

Other funds holding KYMR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return